Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Proof of Concept Study of IV Zoledronic Acid (ZA) 5 mg After Forteo in Postmenopausal Women

NCT00361595 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00361595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00361595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Proof of Concept Study of IV Zoledronic Acid (ZA) 5 mg After Forteo in Postmenopausal Women
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2006
Completion date
April 30, 2008
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis